SGLT2 inhibitors vs placebo
Discontinuation of medication due to adverse events · people with diabetes and CKD
1 finding from 1 review
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease 2018 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 917 participantsVery low